Collagen Cross-Linking in the Management of Microbial Keratitis

REFERENCES

• Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214–221.
   PubMed Web of Science ®Google Scholar
• Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113(1):109–116.
   PubMed Web of Science ®Google Scholar
• Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87(7):834–838.
   PubMed Web of Science ®Google Scholar
• Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27(1):22–27.
   PubMed Web of Science ®Google Scholar
• Saeed A, D’Arcy F, Stack J, Collum LM, Power W, Beatty S. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in ireland. Cornea. 2009;28(3):285–292.
   PubMed Web of Science ®Google Scholar
• Jeng BH, Gritz DC, Kumar AB, et al. Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol. 2010;128(8):1022–1028.
   PubMedGoogle Scholar
• Sharma N, Sachdev R, Jhanji V, Titiyal JS, Vajpayee RB. Therapeutic keratoplasty for microbial keratitis. Curr Opin Ophthalmol. 2010;21(4):293–300.
   PubMed Web of Science ®Google Scholar
• Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology. 1994;101(9):1536–1547.
   PubMed Web of Science ®Google Scholar
• Green M, Chow A, Apel A. Outcomes of combined penetrating keratoplasty and cataract extraction compared with penetrating keratoplasty alone. Clin Experiment Ophthalmol. 2007;35(4):324–329.
   PubMed Web of Science ®Google Scholar
• Bennett HGB, Hay J, Kirkness CM, Seal DV, Devonshire P. Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol. 1998;82(2):137–145.
   PubMed Web of Science ®Google Scholar
• DeMuri GP, Hostetter MK. Resistance to antifungal agents. Pediatric Clinics of North America. 1995;42(3):665–685.
   PubMed Web of Science ®Google Scholar
• Levy SB. Multidrug resistance — a sign of the times. New England J Med. 1998;338(19):1376–1378.
   PubMed Web of Science ®Google Scholar
• Neu HC. The crisis in antibiotic resistance. Science. 1992;257(5073):1064–1073.
   PubMed Web of Science ®Google Scholar
• Kozobolis V, Labiris G, Gkika M, et al. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea. 2010;29(2):235–238.
   PubMed Web of Science ®Google Scholar
• Labiris G, Giarmoukakis A, Larin R, Sideroudi H, Kozobolis VP. Corneal collagen cross-linking in a late-onset graft infectious ulcer: a case report. J Med Case Reports. 2014;8: 180.
   PubMedGoogle Scholar
• Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627.
   PubMed Web of Science ®Google Scholar
• Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf. 2013;11(2):93–108.
   PubMed Web of Science ®Google Scholar
• Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin–ultraviolet type A rays induced cross-linking of corneal collagen. J Cataract Refractive Surg. 2006;32(5):837–845.
   PubMed Web of Science ®Google Scholar
• Vinciguerra P, Albè E, Trazza S, et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology. 2009;116(3):369–378.
   PubMed Web of Science ®Google Scholar
• Coskunseven E, Jankov MR, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refractive Surg. 2008;25(4):371–376.
   Web of Science ®Google Scholar
• Agrawal V. Corneal collagen cross-linking with riboflavin and ultraviolet––a light for keratoconus: results in Indian eyes. Indian J Ophthalmol. 2009;57(2):111.
   PubMed Web of Science ®Google Scholar
• Arbelaez M, Sekito M, Vidal C, Choudhury S. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: one-year results. Oman J Ophthalmol. 2009;2(1):33.
   PubMedGoogle Scholar
• Vinciguerra P. Intraoperative and Postoperative Effects of Corneal Collagen Cross-linking on Progressive Keratoconus. Arch Ophthalmol. 2009;127(10):1258.
   PubMed Web of Science ®Google Scholar
• Fournie P, Galiacy S, Arne JL, Malecaze F. [Corneal collagen cross-linking with ultraviolet-A light and riboflavin for the treatment of progressive keratoconus]. J Fr Ophtalmol. 2009;32(1):1–7.
   PubMed Web of Science ®Google Scholar
• Henriquez MA, Izquierdo L Jr., Bernilla C, Zakrzewski PA, Mannis M. Riboflavin/Ultraviolet A corneal collagen cross-linking for the treatment of keratoconus: visual outcomes and Scheimpflug analysis. Cornea. 2011;30(3):281–286.
   PubMed Web of Science ®Google Scholar
• Kampik D, Koch M, Kampik K, Geerling G. Kollagenvernetzung mittels Riboflavin und UV-A-Strahlung (CXL) bei Keratokonus: zwei-Jahres-Ergebnisse. Klinische Monatsblätter Für Augenheilkunde. 2011;228(06):525–530.
   PubMedGoogle Scholar
• Goldich Y, Marcovich AL, Barkana Y, et al. Clinical and Corneal Biomechanical Changes After Collagen Cross-Linking With Riboflavin and UV Irradiation in Patients With Progressive Keratoconus. Cornea. 2012;31(6):609–614.
   PubMed Web of Science ®Google Scholar
• Asri D, Touboul D, Fournié P, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refractive Surg. 2011;37(12):2137–2143.
   PubMed Web of Science ®Google Scholar
• Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refractive Surg. 2011;37(1):149–160.
   PubMed Web of Science ®Google Scholar
• O’Brart DP. Corneal collagen cross-linking: a review. J Optom. 2014;7(3):113–124.
   PubMedGoogle Scholar
• Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000;78(Suppl 2):211–215.
   PubMedGoogle Scholar
• Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004;44(6):877–885.
   PubMed Web of Science ®Google Scholar
• Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev. 2008;22(2):133–153.
   PubMed Web of Science ®Google Scholar
• Rau H. [A transportable apparatus for UV irradiation in final disinfection of patient rooms]. Dtsch Gesundheitsw. 1960;15:148–151.
   PubMedGoogle Scholar
• Muller G, Goethe H, Herrmann R. [Ship drinking water disinfection using UV irradiation. II]. Zentralbl Bakteriol Orig B. 1972;156(4):361–372.
   PubMedGoogle Scholar
• Martins SAR, Combs JC, Noguera G, et al. Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Opthalmol Vis Sci. 2008;49(8):3402.
   PubMed Web of Science ®Google Scholar
• Hafezi F, Randleman JB. PACK-CXL: defining CXL for Infectious Keratitis. J Refractive Surg. 2014;30(7):438–439.
   PubMed Web of Science ®Google Scholar
• Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012;47(6):493–499.
   PubMed Web of Science ®Google Scholar
• Shah VM, Tandon R, Satpathy G, et al. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea. 2010;29(7):751–757.
   PubMed Web of Science ®Google Scholar
• McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology. 1995;102(12):1943–1948.
   PubMed Web of Science ®Google Scholar
• Betanzos-Cabrera G, Juarez-Verdayes MA, Gonzalez-Gonzalez G, Cancino-Diaz ME, Cancino-Diaz JC. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res. 2009;42(1):43–48.
   PubMed Web of Science ®Google Scholar
• Bertino JS Jr. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol. 2009;3:507–521.
   PubMedGoogle Scholar
• Schnitzler E, Sporl E, Seiler T. [Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients]. Klin Monbl Augenheilkd. 2000;217(3):190–193.
   PubMed Web of Science ®Google Scholar
• Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/Riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590–594.
   PubMed Web of Science ®Google Scholar
• Muller L, Thiel MA, Kipfer-Kauer AI, Kaufmann C. Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klin Monbl Augenheilkd. 2012;229(4):411–415.
   PubMed Web of Science ®Google Scholar
• Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea. 2010;29(12):1353–1358.
   PubMed Web of Science ®Google Scholar
• Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect. 2013;3(1):47.
   PubMedGoogle Scholar
• Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35–40.
   PubMed Web of Science ®Google Scholar
• Bertollo CM, Oliveira ACP, Rocha LTS, Costa KA, Nascimento EB, Coelho MM. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol. 2006;547(1–3):184–191.
   PubMed Web of Science ®Google Scholar
• Takami Y, Gong H, Amemiya T. Riboflavin deficiency induces ocular surface damage. Ophthalmic Res. 2004;36(3):156–165.
   PubMed Web of Science ®Google Scholar
• Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of fungal keratitis from fusarium infection by corneal cross-linking. Cornea. 2012;31(2):176–180.
   PubMed Web of Science ®Google Scholar
• Zhang Z-Y. Corneal Cross-linking for the Treatment of Fungal Keratitis. Cornea. 2013;32(2):217–218.
   PubMed Web of Science ®Google Scholar
• Sağlk A, Uçakhan ÖÖ, Kanpolat A. Ultraviolet A and riboflavin therapy as an adjunct in corneal ulcer refractory to medical treatment. Eye Contact Lens: Sci Clin Pract. 2013;39(6):413–415.
   PubMed Web of Science ®Google Scholar
• Richoz O, Gatzioufas Z, Hafezi F. Corneal Collagen Cross-Linking for the Treatment of Acanthamoeba Keratitis. Cornea. 2013;32(10):e189.
   PubMed Web of Science ®Google Scholar
• Mattila JS, Korsbäck A, Krootila K, Holopainen JM. Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation. Acta Ophthalmologica. 2013;91(5):e410–e411.
   PubMed Web of Science ®Google Scholar
• Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol. 2013;97(5):669–671.
   PubMed Web of Science ®Google Scholar
• Berra M, Galperin G, Boscaro G, et al. Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea. 2013;32(2):174–178.
   PubMed Web of Science ®Google Scholar
• Arance-Gil Á, Gutiérrez-Ortega ÁR, Villa-Collar C, Nieto-Bona A, Lopes-Ferreira D, González-Méijome JM. Corneal cross-linking for Acanthamoeba keratitis in an orthokeratology patient after swimming in contaminated water. Contact Lens Anterior Eye. 2014;37(3):224–227.
   PubMed Web of Science ®Google Scholar
• Wong RLM, Gangwani RA, Yu LWH, Lai JSM. New treatments for bacterial keratitis. J Ophthalmol. 2012;2012:1–7.
   Google Scholar
• Del Buey MA, Cristobal JA, Casas P, et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol. 2012;153(3):399–404.
   PubMed Web of Science ®Google Scholar
• Ehlers N, Hjortdal J, Nielsen K, Søndergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refractive Surg. 2009;25(9):S803–S806.
   PubMed Web of Science ®Google Scholar
• Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refractive Surg. 2012;28(10):706–713.
   PubMed Web of Science ®Google Scholar
• Makdoumi K, Mortensen J, Sorkhabi O, Malmvall B-E, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2011;250(1):95–102.
   PubMed Web of Science ®Google Scholar
• Said DG, Elalfy MS, Gatzioufas Z, et al. Collagen cross-linking with Photoactivated Riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377–1382.
   PubMed Web of Science ®Google Scholar
• Bamdad S, Malekhosseini H, Khosravi A. Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers. Cornea. 2015;34(4):402–406.
   PubMed Web of Science ®Google Scholar
• Berry M, Gurung A, Easty DL. Toxicity of antibiotics and antifungals on cultured human corneal cells: effect of mixing, exposure and concentration. Eye (Lond). 1995;9(Pt 1):110–115.
   PubMedGoogle Scholar
• Panda A, Krishna SN, Kumar S. Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea. 2012;31(10):1210–1213.
   PubMed Web of Science ®Google Scholar
• Skaat A, Zadok D, Goldich Y, et al. Riboflavin/UVA photochemical therapy for severe infectious keratitis. Eur J Ophthalmol. 2014;24(1):21–28.
   PubMed Web of Science ®Google Scholar
• Kymionis GD, Kankariya VP, Kontadakis GA. Combined treatment with flap amputation, phototherapeutic keratectomy, and collagen crosslinking in severe intractable post-LASIK atypical mycobacterial infection with corneal melt. J Cataract Refractive Surg. 2012;38(4):713–715.
   PubMed Web of Science ®Google Scholar
• Kymionis GD, Mikropoulos DG, Portaliou DM, Voudouragkaki IC, Kozobolis VP, Konstas AGP. An Overview of Corneal Collagen Cross-Linking (CXL). Adv Ther. 2013;30(10):858–869.
   PubMed Web of Science ®Google Scholar
• Bettis DI, Hsu M, Moshirfar M. Corneal collagen cross-linking for nonectatic disorders: a systematic review. J Refractive Surg. 2012;28(11):798–807.
   PubMed Web of Science ®Google Scholar
• Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011;118(2):324–331.
   PubMed Web of Science ®Google Scholar
• Mravicic I, Dekaris I, Gabric N, Romac I, Glavota V, Sviben M. Trichophyton Spp. fungal keratitis in 22 years old female contact lenses wearer. Coll Antropol. 2010;34(Suppl 2):271–274.
   PubMedGoogle Scholar
• Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15(4):321–327.
   PubMedGoogle Scholar
• Kashiwabuchi RT, Carvalho FR, Khan YA, Hirai F, Campos MS, McDonnell PJ. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol. 2013;251(2):521–527.
   PubMed Web of Science ®Google Scholar
• Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci. 2010;51(8):3950–3953.
   PubMed Web of Science ®Google Scholar
• Shetty R, Nagaraja H, Jayadev C, Shivanna Y, Kugar T. Collagen crosslinking in the management of advanced non-resolving microbial keratitis. Br J Ophthalmol. 2014;98(8):1033–1035.
   PubMed Web of Science ®Google Scholar
• Das S, Samant M, Garg P, Vaddavalli PK, Vemuganti GK. Role of confocal microscopy in deep fungal keratitis. Cornea. 2009;28(1):11–13.
   PubMed Web of Science ®Google Scholar
• Papaioannou L, Miligkos M, Papathanassiou M. Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis. Cornea. 2016;35(1):62–71.
   PubMed Web of Science ®Google Scholar
• Prajna NV, Srinivasan M, Lalitha P, et al. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013;131(8):1088–1089.
   PubMed Web of Science ®Google Scholar
• Tabibian D, Richoz O, Riat A, Schrenzel J, Hafezi F. Accelerated photoactivated chromophore for keratitis–corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refractive Surg. 2014;30(12):855–857.
   PubMed Web of Science ®Google Scholar
• Tabibian D, Richoz O, Hafezi F. PACK-CXL: corneal Cross-linking for Treatment of Infectious Keratitis. J Ophthalmic Vis Res. 2015;10(1):77–80.
   PubMedGoogle Scholar
• Baginski M, Czub J, Sternal K. Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies. Chem Rec. 2006;6(6):320–332.
   PubMed Web of Science ®Google Scholar
• Panjwani N. Pathogenesis of acanthamoeba keratitis. Ocul Surf. 2010;8(2):70–79.
   PubMed Web of Science ®Google Scholar
• Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol. 2006;17(4):327–331.
   PubMed Web of Science ®Google Scholar
• Bouheraoua N, Labbe A, Chaumeil C, Liang Q, Laroche L, Borderie V. [Acanthamoeba keratitis]. J Fr Ophtalmol. 2014;37(8):640–652.
   PubMed Web of Science ®Google Scholar
• Garduno-Vieyra L, Gonzalez-Sanchez CR, Hernandez-Da Mota SE. Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report. Case Rep Ophthalmol. 2011;2(2):291–295.
   PubMedGoogle Scholar
• Kashiwabuchi RT, Carvalho FR, Khan YA, et al. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci. 2011;52(13):9333–9338.
   PubMed Web of Science ®Google Scholar